Intracoronary Hypothermia as a Prevention of Reperfusion Injury in Myocardial Infarction.

Recruiting N/A Interventional Study
Myocardial Infarction ST-Elevation Myocardial Infarction (STEMI) Reperfusion Injury Microvascular Occlusion
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Acute myocardial infarction with ST segment elevation is often accompanied by a totally occluded coronary artery. Which has deleterious effects on heart muscle. Primary percutaneous coronary intervention is the most effective mode of treatment for ST-elevation myocardial infarction (STEMI) patients. Despite the restoration of the blood flow, 30-60% of patients develop microvascular obstruction, wh…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Acute ST-elevation myocardial infarction * Time from onset of symptoms less than 12 hours * Given informed consent Exclusion Criteria: * Contraindication to MRI * Cardiogenic shock * Conduction disturbance: Atrioventricular block: 2nd and 3rd degree. SA block. * Sick sinus s…
Contacts

Christina Nasekina

7-983-239-63-70

christina.nasekina@mail.ru

CONTACT

Yury Bogdanov

7-913-520-77-77

yury.bogdanov.md@gmail.com

CONTACT